Patient Care

Merabet, OD, PhD, MPH, discusses what his research on motion processing reveals about the neural roots of CVI and where diagnostic tools like neuroimaging and eye tracking are headed.

Catch up on the top stories in optometry during the week of August 31-September 4.

Cerebral visual impairment is now the leading cause of childhood vision loss. Three experts explain the history, science, and clinical signs eye care providers need to know.

Catch up on the top stories in optometry during the week of August 10-14.

A recent study examined the current state of readability in ophthalmic letters addressed to patients following their appointment and provides recommended solutions for improvement.

Physicians recommend a Mediterranean or similar diet to slow the progression of age-related macular degeneration, the leading cause of irreversible vision loss in older adults.

Through at home delivery, and in-office dispense in permitted states, Orasis Pharmaceuticals and BlinkRx aim to improve accessibility of Qlosi eye drops for presbyopia treatment.

A 10-year analysis finds latanoprost accounts for 40% of glaucoma prescriptions in New Zealand.

A cross-sectional study of nearly 10,000 nursing home residents found a clear dose-response relationship between vision loss and cognitive impairment, with blind residents having nearly 3 times the odds of cognitive loss compared with those with normal vision.

A systematic review of 22 studies found Demodex infestation strongly associated with MGD, with MGD prevalence reaching 92% to 99% in symptomatic Demodex blepharitis and significantly worse meibomian gland structure and function in infested patients.

A VA case report documents rapid PDR progression to intravitreal anti-VEGF treatment in a patient 6 months after semaglutide initiation, reinforcing AOA monitoring guidance for GLP-1 patients with preexisting DR.

Daniel C. Brocks, MD, BostonSight chief medical officer, discusses a few of the company's studies, the patients they serve, and what the broader eye care community may be missing.

Jessilin Quint, OD, MBA, MS, FAAO, shares strategies for improving adherence, building trust through patient communication, and more.

Sheila Morrison, OD, MS, explores the clinical intersection of dry eye disease and myopia control in pediatric patients—and why that intersection matters more than many practitioners realize.

Henry, MS, OD, presented a talk on how AI can help alleviate burnout for ODs during Vision Expo 2026 in Orlando, Florida.

Nathan Lighthizer, OD, FAAO, presented on laser trabeculoplasty for glaucoma management at this year's conference.

Researchers examined 3 primary associations: the risk of developing uveitis following an IMID diagnosis, the odds of having a prior IMID among uveitis patients, and the risk of developing an IMID after a uveitis diagnosis.

Julia Pulliam, OD, FAAO, highlights how working in an academic medical center provides significant advantages for managing complex conditions like uveitis.

Pathik P. Amin, OD, FAAO, details his segment of an educational track session on glaucoma at this year's conference.

Why school screenings fall short—and how your practice can fill the gap.

ACP says the label “provider” blurs clinical roles, commercializes care, and erodes trust—urging words that protect medical ethics and relationships.

Smart glasses with artificial intelligence assistants can make a world of difference for those with vision impairment.

A conversation with survivor and advocate Jasmine Grace Marino.

IPV is defined as physical violence, sexual violence, stalking, or psychological aggression that is committed by a current or former spouse or dating partners.

Dan Ignaszewski, executive director of the Alliance for Eye and Vision Research and the National Alliance for Eye and Vision Research, provides insight into the new campaign and how to get involved.